US2012077182A1PendingUtilityA1
Additive solution for blood preservation
Individually held — no corporate assignee on recordPriority: Nov 16, 2001Filed: Dec 2, 2011Published: Mar 29, 2012
Est. expiryNov 16, 2021(expired)· nominal 20-yr term from priority
A01N 1/126A01N 1/10C12N 5/0641
63
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method for the storage of red blood cells provides for mixing an additive solution with packed red blood cells to create a suspension of red blood cells. The method further provides for reducing the oxygen in the suspension of red blood cells; and storing the suspension of red blood cells under oxygen-depleted storage.
Claims
exact text as granted — not AI-modified1 . A method for the storage of red blood cells comprising the steps of:
mixing an additive solution with packed red blood cells creating a suspension of red blood cells; reducing the oxygen in said suspension of red blood cells; and storing said suspension of red blood cells under oxygen-depleted storage.
2 . The method according to claim 1 , further comprising first mixing whole blood with an anticoagulant solution, concentrating the red blood cells from said whole blood and separating the plasma thereby creating packed red blood cells.
3 . The method according to claim 1 , wherein said additive solution comprises the following concentrations of about 0.5 to 4.0 mmole/liter of adenine, about 50 to 150 mmole/liter of dextrose, about 20 to 70 mmole/liter of mannitol, about 0 to 100 mmole/liter of NaCl and, about 2 to 20 mmole/liter of NaH 2 PO 4 .
4 . The method according to claim 1 , wherein said additive solution comprises about 2 mmole/liter adenine, about 110 mmole/liter dextrose, about 55 mmole/liter NaCl, and about 12 mmole/liter NaH 2 PO 4 .
5 . The method according to claim 1 , wherein said additive solution has an adjusted pH of about 6.5.
6 . The method of claim 1 , wherein said suspension of red blood cells are continuously stored and maintained during said storage period.
7 . The method of claim 1 , wherein said suspension of stored red blood cells are stored at a storage temperature of 4° C.
8 . The method of claim 1 , further comprising the step of addition of a metabolic supplement to said suspension of stored red blood cells at least once during refrigerated storage.
9 . The method of claim 8 , wherein said metabolic supplement comprises pyruvate, inosine, adenine and optionally dibasic sodium phosphate and/or monobasic sodium phosphate.
10 . The method of claim 1 , wherein the additive solution is AS-3 or EAS61.Join the waitlist — get patent alerts
Track US2012077182A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.